Drugs / dihydroergotine
last change Feb 2026 re-read 3 minutes ago

dihydroergotine

Developed for
parkinsonian disorder
Investigated by
Second Affiliated Hospital of Soochow University

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06319118 Oct 2023 → Sep 2025 parkinsonian disorder Second Affiliated Hospital of Soochow University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as dihydroergotine ClinicalTrials.gov intervention name — accepted as the source's own label NCT06319118 ↗